Combining stellate ganglion block with prolonged exposure for ptsd: a randomized clinical trial

The University of Texas Health Science Center of San Antonio will receive $3 million in cooperative agreement funding from the Department of the Army Medical Command to conduct a randomized clinical trial combining stellate ganglion block with prolonged exposure therapy for post-traumatic stress disorder (PTSD). The four-year award under the Military Medical Research and Development program (CFDA 12.420) aims to investigate medical solutions for traumatic battlefield injuries and transform military and civilian health care through innovative research. As the prime awardee, the University of Texas Health Science Center will collaborate with sub-awardee University of Texas System to enroll study participants and evaluate the safety and efficacy of combining a minimally invasive nerve block procedure with evidence-based psychotherapy for treating PTSD. Results of the clinical trial could yield improved treatment options for PTSD among active military service members and veterans.